Skip to main content
. 2021 Mar 6;11(3):53. doi: 10.1038/s41408-021-00445-z

Fig. 2. Time to treatment failure of responders (according to revised clinico-hematological ELN criteria) (ITT Population).

Fig. 2

The X axis is the duration from the end of the core study (in months), and not visits. Note that as this is an ongoing study, patients currently in the study have received varying durations of therapy. At the time of these analyses, 31 patients were still in the study.